DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

STEMCELLS, INC. (NASDAQ: STEM)

0.53 -0.01 (-2.66%)

Quote as of


company name or ticker

Recent Quotes

STEM $0.53 -2.66%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.55
Previous Close $0.55
Daily Range $0.53 - $0.55
52-Week Range $0.49 - $2.43
Market Cap $56.1M
P/E Ratio -1.03
Dividend (Yield) $0.00 (0.0%)
Volume 811,882
Average Daily Volume 2,969,021
Current FY EPS -$0.41

Sector

Healthcare

Industry

Drug Makers

STEMCELLS, INC. (STEM) Description

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders. Website: http://www.stemcellsinc.com/

News & Commentary

Cloning: A Stem Cell Revolution?

Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?

Will StemCells (STEM) Continue to Surge Higher? - Tale of the Tape

Health Care Sector Update for 06/04/2015: RGLS, NVGN, STEM

StemCells (STEM) Worth Watching: Stock Rises 10.7% - Tale of the Tape

Cantor: Time To Buy StemCells

Benzinga's Top Initiations

HC Wainwright: Buy StemCells, It's Worth $1/Share

StemCells (STEM) Q1 2015 Results - Earnings Call Webcast

Dissecting StemCells Latest Capital Raise

StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal C

StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal Cord Injury

Porat To Google Just One Of The Week's Top Management Changes; Here Are 7 More

See More STEM News...

STEM's Top Competitors

STEM $0.53 (-2.66%)
Current stock: STEM
GILD $115.04 (-0.84%)
Current stock: GILD
CELG $119.52 (1.10%)
Current stock: CELG
BIIB $404.28 (-0.28%)
Current stock: BIIB